Syra Average Inventory from 2010 to 2026
| SYRA Stock | USD 0.08 0 2.32% |
Average Inventory | First Reported 2010-12-31 | Previous Quarter 21.2 K | Current Value 18.9 K | Quarterly Volatility 1.2 K |
Check Syra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syra Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.1 K, Other Operating Expenses of 14.2 M or Total Operating Expenses of 6.5 M, as well as many indicators such as Price To Sales Ratio of 0.41, Dividend Yield of 0.0 or PTB Ratio of 0.98. Syra financial statements analysis is a perfect complement when working with Syra Health Valuation or Volatility modules.
Syra | Average Inventory | Build AI portfolio with Syra Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Syra Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Syra Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Syra Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Syra Health Corp Stock:Check out the analysis of Syra Health Correlation against competitors. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Syra Health. If investors know Syra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Syra Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.08) | Revenue Per Share | Quarterly Revenue Growth (0.25) | Return On Assets | Return On Equity |
Understanding Syra Health Corp requires distinguishing between market price and book value, where the latter reflects Syra's accounting equity. The concept of intrinsic value—what Syra Health's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Syra Health's price substantially above or below its fundamental value.
Please note, there is a significant difference between Syra Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Syra Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Syra Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.